Works matching IS 10538569 AND DT 2021 AND VI 30

Results: 219

Measured and accounted‐for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 277, doi. 10.1002/pds.5189
By:
- Roy, Jason;
- Mitra, Nandita
Publication type:
Article
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–2017.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 390, doi. 10.1002/pds.5187
By:
- Bykov, Katsiaryna;
- Patorno, Elisabetta;
- Franklin, Jessica M.;
- Vine, Seanna M.;
- Bateman, Brian T.
Publication type:
Article
Confirming diagnoses of acute pancreatitis with commonly available electronic data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 313, doi. 10.1002/pds.5185
By:
- Nichols, Gregory A.;
- Déruaz‐Luyet, Anouk;
- Iliev, Hristo;
- Brodovicz, Kimberly G.
Publication type:
Article
Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 400, doi. 10.1002/pds.5182
By:
- Webster‐Clark, Michael
Publication type:
Article
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 379, doi. 10.1002/pds.5180
By:
- Gomes, Tara;
- Campbell, Tonya;
- Tadrous, Mina;
- Mamdani, Muhammad M.;
- Paterson, J. Michael;
- Juurlink, David N.
Publication type:
Article
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 350, doi. 10.1002/pds.5174
By:
- Segec, Andrej;
- Slattery, Jim;
- Morales, Daniel R.;
- Januskiene, Justina;
- Kurz, Xavier;
- Arlett, Peter
Publication type:
Article
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 292, doi. 10.1002/pds.5166
By:
- Toussi, Massoud;
- Shlaen, Margarita;
- Coste, Florence;
- Voogd, Hanka;
- Dimos, Vasilis;
- Kaplan, Sigal
Publication type:
Article
Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 342, doi. 10.1002/pds.5163
By:
- Borges, Fábio C.;
- Ramos, Catarina;
- Ramos, Adriana;
- Mendes, Gonçalo P.;
- Murteira, Rodrigo;
- Soares, Patrícia;
- Furtado, Claudia;
- Miranda, Ana C.;
- Costa, Filipa A.
Publication type:
Article
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 334, doi. 10.1002/pds.5162
By:
- Januskiene, Justina;
- Segec, Andrej;
- Slattery, Jim;
- Genov, Georgy;
- Plueschke, Kelly;
- Kurz, Xavier;
- Arlett, Peter
Publication type:
Article
Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 320, doi. 10.1002/pds.5161
By:
- Thurin, Nicolas H.;
- Lassalle, Régis;
- Schuemie, Martijn;
- Pénichon, Marine;
- Gagne, Joshua J.;
- Rassen, Jeremy A.;
- Benichou, Jacques;
- Weill, Alain;
- Blin, Patrick;
- Moore, Nicholas;
- Droz‐Perroteau, Cécile
Publication type:
Article
New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self‐reports.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 304, doi. 10.1002/pds.5160
By:
- Brüne, Manuela;
- Andrich, Silke;
- Haastert, Burkhard;
- Kaltheuner, Matthias;
- Icks, Andrea
Publication type:
Article
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 283, doi. 10.1002/pds.5119
By:
- Toussi, Massoud;
- Isabelle, Bardoulat;
- Tcherny‐Lessenot, Stephanie;
- Voogd, Hanka;
- Dimos, Vasilis;
- Kaplan, Sigal
Publication type:
Article
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 371, doi. 10.1002/pds.5118
By:
- González‐Bermejo, Diana;
- Rayón‐Iglesias, Pilar;
- Rodríguez‐Pascual, Alfonso;
- Álvarez‐Gutiérrez, Arturo;
- Fernández‐Dueñas, Ana;
- Montero‐Corominas, Dolores;
- Huerta‐Álvarez, Consuelo
Publication type:
Article
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 395, doi. 10.1002/pds.5096
By:
- Hallvik, Sara E.;
- Johnston, Kirbee;
- Geddes, Jonah;
- Leichtling, Gillian;
- Korthuis, P. Todd;
- Hartung, Daniel M.
Publication type:
Article
Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 360, doi. 10.1002/pds.5081
By:
- Tervonen, Hanna E;
- Schaffer, Andrea L;
- Luckett, Tim;
- Phillips, Jane;
- Litchfield, Melisa;
- Todd, Adam;
- Pearson, Sallie‐Anne
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 402, doi. 10.1002/pds.5044
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 1, doi. 10.1002/pds.5314
Publication type:
Article
Developing algorithms for identifying major structural birth defects using automated electronic health data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 266, doi. 10.1002/pds.5177
By:
- Kharbanda, Elyse O.;
- Vazquez‐Benitez, Gabriela;
- DeSilva, Malini B.;
- Spaulding, Alicen B.;
- Daley, Matthew F.;
- Naleway, Allison L.;
- Irving, Stephanie A.;
- Klein, Nicola P.;
- Tseng, Hung Fu;
- Jackson, Lisa A.;
- Hambidge, Simon J.;
- Olaiya, Oluwatosin;
- Panozzo, Catherine A.;
- Myers, Tanya R.;
- Romitti, Paul A.
Publication type:
Article
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 201, doi. 10.1002/pds.5176
By:
- Visanji, Naomi P.;
- Madan, Piyush;
- Lacoste, Alix M. B.;
- Buleje, Italo;
- Han, Yanyan;
- Spangler, Scott;
- Kalia, Lorraine V.;
- Hensley Alford, Sharon;
- Marras, Connie
Publication type:
Article
Influence of statin‐potency on the risk of kidney disease – A nationwide cohort study using laboratory data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 210, doi. 10.1002/pds.5173
By:
- Citarella, Anna;
- Linder, Marie;
- Cammarota, Simona;
- Sundström, Anders;
- Kieler, Helle
Publication type:
Article
Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 248, doi. 10.1002/pds.5171
By:
- Seesaghur, Anouchka;
- Petruski‐Ivleva, Natalia;
- Banks, Victoria;
- Wang, Jocelyn Ruoyi;
- Mattox, Pattra;
- Hoeben, Edwin;
- Maskell, Joe;
- Neasham, David;
- Reynolds, Shannon L.;
- Kafatos, George
Publication type:
Article
Accuracy of diagnoses of inflammatory arthritis in administrative hospitalization databases.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 257, doi. 10.1002/pds.5157
By:
- Ward, Michael M.
Publication type:
Article
Ondansetron use in early pregnancy and the risk of late pregnancy outcomes.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 114, doi. 10.1002/pds.5151
By:
- Suarez, Elizabeth A.;
- Boggess, Kim;
- Engel, Stephanie M.;
- Stürmer, Til;
- Lund, Jennifer L.;
- Funk, Michele Jonsson
Publication type:
Article
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 237, doi. 10.1002/pds.5150
By:
- Arana, Alejandro;
- Margulis, Andrea V;
- Varas‐Lorenzo, Cristina;
- Bui, Christine L;
- Gilsenan, Alicia;
- McQuay, Lisa J;
- Reynolds, Maria;
- Rebordosa, Cristina;
- Franks, Billy;
- Vogel, Stefan;
- Appenteng, Kwame;
- Perez‐Gutthann, Susana
Publication type:
Article
Medication‐related problems in older people in Catalonia: A real‐world data study.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 220, doi. 10.1002/pds.5149
By:
- Troncoso‐Mariño, Amelia;
- López‐Jiménez, Tomás;
- Roso‐Llorach, Albert;
- Villén, Noemí;
- Amado‐Guirado, Ester;
- Guisado‐Clavero, Marina;
- Fernández‐Bertolin, Sergio;
- Pons Vigues, Mariona;
- Foguet‐Boreu, Quintí;
- Violán, Concepción
Publication type:
Article
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 229, doi. 10.1002/pds.5146
By:
- Ruigómez, Ana;
- Brobert, Gunnar;
- Vora, Pareen;
- García Rodríguez, Luis A.
Publication type:
Article
Risk of age‐related macular degeneration in aspirin users and non‐aspirin users: A population‐based cohort study in Taiwan.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 178, doi. 10.1002/pds.5145
By:
- Lee, Wan‐Ju Annabelle;
- Yang, Yea‐Huei Kao;
- Cheng, Ching‐Lan
Publication type:
Article
Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 144, doi. 10.1002/pds.5144
By:
- Shmuel, Shahar;
- Pate, Virginia;
- Pepin, Marc J.;
- Bailey, Janine C.;
- Hanson, Laura C.;
- Stürmer, Til;
- Naumann, Rebecca B.;
- Golightly, Yvonne M.;
- Gnjidic, Danijela;
- Lund, Jennifer L.
Publication type:
Article
Ondansetron use in early pregnancy and the risk of miscarriage.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 103, doi. 10.1002/pds.5143
By:
- Suarez, Elizabeth A.;
- Boggess, Kim;
- Engel, Stephanie M.;
- Stürmer, Til;
- Lund, Jennifer L.;
- Jonsson Funk, Michele
Publication type:
Article
Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 157, doi. 10.1002/pds.5127
By:
- Koto, Ruriko;
- Nakajima, Akihiro;
- Horiuchi, Hideki;
- Yamanaka, Hisashi
Publication type:
Article
Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 189, doi. 10.1002/pds.5125
By:
- Kalemeera, Francis;
- Godman, Brian;
- Stergachis, Andy;
- Rennie, Timothy
Publication type:
Article
Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 126, doi. 10.1002/pds.5112
By:
- Liu, Wei;
- Menzin, Talia J.;
- Woods, Corinne M.;
- Haug, Nicole R.;
- Li, Jie;
- Mathew, Justin A.;
- Nguyen, Christine P.;
- Chai, Grace P.;
- Moeny, David G.;
- Shinde, Mayura
Publication type:
Article
Baseline anticholinergic burden from medications predicts poorer baseline and long‐term health‐related quality of life in 16 675 men and women of EPIC‐Norfolk prospective population‐based cohort study.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 135, doi. 10.1002/pds.5085
By:
- Yrjana, Kaisa R.;
- Neal, Samuel R.;
- Soiza, Roy L.;
- Keevil, Victoria;
- Luben, Robert N.;
- Wareham, Nicholas J.;
- Khaw, Kay‐Tee;
- Myint, Phyo Kyaw
Publication type:
Article
Treatment resistant depression incidence and prevalence using the French nationwide claims database.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 169, doi. 10.1002/pds.5082
By:
- Bosco‐Lévy, Pauline;
- Grelaud, Angela;
- Blin, Patrick;
- Astruc, Bernard;
- Falissard, Bruno;
- Llorca, Pierre‐Michel;
- Bernard, Marie‐Agnès;
- Lassalle, Régis;
- Moore, Nicholas;
- Droz‐Perroteau, Cécile
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 275, doi. 10.1002/pds.5042
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 1, doi. 10.1002/pds.5041
Publication type:
Article
A joint industry‐sponsored data monitoring committee model for observational, retrospective drug safety studies in the real‐world setting.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 9, doi. 10.1002/pds.5172
By:
- Major‐Pedersen, Atheline;
- McCullen, Mary Kate;
- Sabol, Mary Elizabeth;
- Adetunji, Omolara;
- Massaro, Joseph;
- Neugut, Alfred I.;
- Sosa, Julie Ann;
- Hollenberg, Anthony N.
Publication type:
Article
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 97, doi. 10.1002/pds.5168
By:
- Huang, Kelly;
- Lin, Fang‐Ju;
- Ou, Huang‐Tz;
- Hsu, Chien‐Ning;
- Huang, Ling‐Ya;
- Wang, Chi‐Chuan;
- Toh, Sengwee
Publication type:
Article
Real world data to identify target population for new CAR‐T therapies.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 78, doi. 10.1002/pds.5165
By:
- Belleudi, Valeria;
- Trotta, Francesco;
- Fortinguerra, Filomena;
- Poggi, Francesca R.;
- Olimpieri, Odoardo;
- Santelli, Enrica;
- Cozzi, Ilaria;
- Michelozzi, Paola;
- Addis, Antonio
Publication type:
Article
Medications used disproportionately during pregnancy: Priorities for research on the risks and benefits of medications when used during pregnancy.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 53, doi. 10.1002/pds.5131
By:
- Havard, Alys;
- Barbieri, Sebastiano;
- Hanly, Mark;
- Perez‐Concha, Oscar;
- Tran, Duong T.;
- Kennedy, Debra;
- Jorm, Louisa R.
Publication type:
Article
Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: An interrupted time series with segmented regression analysis.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 17, doi. 10.1002/pds.5140
By:
- Jang, Suhyun;
- Jeong, Sohyun;
- Kang, Eunjeong;
- Jang, Sunmee
Publication type:
Article
Patterns of anticonvulsant use and adverse drug events in older adults.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 28, doi. 10.1002/pds.5139
By:
- Moura, Lidia M. V. R.;
- Smith, Jason R.;
- Yan, Zhiyu;
- Blacker, Deborah;
- Schwamm, Lee H.;
- Newhouse, Joseph P.;
- Hernandez‐Diaz, Sonia;
- Hsu, John
Publication type:
Article
Characteristics associated with time‐to‐treatment initiation for chronic Hepatitis C with new direct acting antivirals.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 86, doi. 10.1002/pds.5138
By:
- Karmarkar, Taruja;
- Padula, William V.;
- Gaskin, Darrell J.;
- Watson, Eric;
- Rodriguez, Carla V.
Publication type:
Article
Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 45, doi. 10.1002/pds.5136
By:
- Leonard, James B.;
- Seung, Hyunuk;
- Klein‐Schwartz, Wendy
Publication type:
Article
Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 65, doi. 10.1002/pds.5152
By:
- Ingrasciotta, Ylenia;
- Sultana, Janet;
- Formica, Dario;
- Ientile, Valentina;
- Aiello, Andrea;
- Chinellato, Alessandro;
- Tari, Daniele Ugo;
- Gini, Rosa;
- Pastorello, Maurizio;
- Scondotto, Salvatore;
- Cananzi, Pasquale;
- Traversa, Giuseppe;
- Rossi, Mariangela;
- Santoro, Domenico;
- Trifirò, Gianluca
Publication type:
Article
Trends in HbA<sub>1c</sub> thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 37, doi. 10.1002/pds.5129
By:
- Ambrož, Martina;
- Vries, Sieta T.;
- Hoogenberg, Klaas;
- Denig, Petra
Publication type:
Article
Proton pump inhibitors and chronic kidney disease: Reevaluating the evidence from a randomized controlled trial.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 4, doi. 10.1002/pds.5101
By:
- Gerstman, B. Burt
Publication type:
Article
Leveraging neuropathological data in pharmacoepidemiology: A promising approach for dementia prevention?
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 1, doi. 10.1002/pds.5068
By:
- Marcum, Zachary A.;
- Keene, C. Dirk;
- Larson, Eric B.
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 102, doi. 10.1002/pds.5040
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 1, doi. 10.1002/pds.5304
Publication type:
Article